Your browser doesn't support javascript.
loading
KRAS mutation in primary ovarian serous borderline tumors correlates with tumor recurrence.
McHenry, Austin; Rottmann, Douglas A; Buza, Natalia; Hui, Pei.
Affiliation
  • McHenry A; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
  • Rottmann DA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Buza N; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
  • Hui P; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. pei.hui@yale.edu.
Virchows Arch ; 483(1): 71-79, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37219599
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Cystadenoma, Serous / Cystadenocarcinoma, Serous Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Virchows Arch Journal subject: BIOLOGIA MOLECULAR / PATOLOGIA Year: 2023 Document type: Article Affiliation country: United States Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Cystadenoma, Serous / Cystadenocarcinoma, Serous Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Virchows Arch Journal subject: BIOLOGIA MOLECULAR / PATOLOGIA Year: 2023 Document type: Article Affiliation country: United States Country of publication: Germany